Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies has informed BSE that its Board will meet on 6th May 2025 at 3:00 PM at its Ahmedabad registered office. Key agenda items include considering and approving the draft Valuation Report for issuing equity shares through a share-swap arrangement, and approving the notice for an Extra-Ordinary General Meeting (EGM) of shareholders. The company has also closed its insider trading window from 1st May 2025 until 48 hours after the board meeting concludes. The Managing Director Bhumishth Patel has signed the intimation.
A share-swap equity issuance typically signals an acquisition or strategic investment where the company pays with its own shares rather than cash; shareholders should watch for EGM details and the target involved, as this could dilute holdings or add a new business line.